Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 19 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research

Fee For Service(FFS)

Full Time Equivalent(FTE)

Medicinal Chemistry

Synthetic Chemistry

Analytical Chemistry

Biology Research

Structural Biology

Cell Biology

Computational Biology & Molecular Modeling

Enzymology & Molecular Interactions

Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients

Route Selection

Production Process Optimization

Clinical Sample Production

Impurity Traceability & Control

Generic Drug Process Study & Filing

Innovative Drug Process Study & Filing

Pharmaceutical preparation

Preformulation Study

Formulation Technology Research

Preparation Quality Research

Laboratory-scale Preparation Testing

Pilot-scale Preparation Testing

GMP-based Clinical Sample Production & Packaging

Formulation Stability Study

Consistency Evaluation

Analytical Method Development and Quality Control
CMC Filings
03 Preclinical Research
Pharmacology & Pharmacodynamics

Tumor Models

Digestive System Disease Models

Endocrine & Metabolic Disease Models

Inflammatory & Immune Diseases Models

Neural System Disease Models

Other Disease Models

Ocular Diseases Models

Cardiovascular Model

Drug Safety Evaluation

Pharmacology & Toxicology Study

Safety Pharmacology

Histopathological Study

Clinicopathological Study

Drug Safety Evaluation Basic Information

Toxicokinetics

Pharmacokinetics

In Vitro Pharmacokinetic Assays

In Vivo Pharmacokinetic Assays

Bioanalysis

Macromolecular Drugs Bioanalysis

Micromolecular Drugs Bioanalysis

IND Filings
01 One-stop Integrated Services
Drug Discovery Platform
Pharmaceutical Research Platform
Preclinical Research Services
Chemical Drug Development
One-stop API Process R&D Department
Medicilon's CDMO Service Platform
Pharmaceutical Research CDMO Service Platform
Translational Medicine Platform
02 Innovative Drug Services
Nucleic Acid Drug R&D Platform
Non-clinical Research for Cellular Immunotherapies
mRNA Vaccine Bioanalysis Platform
PROTAC Drug Discovery Research Platform
ADC R&D Service Platform
03 Key Technical Services for Drug R&D
Green Chemistry Platform
Process Department Solid Form Screening Platform
SEND Format Conversion Platform
Flow Cytometry Technology Platform
Safety Assessment Lab of Process Chemistry
Drug Forming Research Platform
Metabolite Identification (MetID) Service Platform
Cytokine and Biomarker Detection Platform
04 Drug Efficacy Evaluation for Common Diseases
Rodent Cerebrovascular Disease Drug Efficacy Evaluation System
Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases
IO Pharmacodynamic Model Evaluation Platform
05 Advanced Preparation R&D
Skin Topical Preparation R&D
Ophthalmic drug R&D platform
Inhalation drug R&D platform
06 Drug Analysis
07 Public Services
CLIENT CENTER
Intellectual Property Protection
Downloads
Partnerships
Newsletters
U.S.

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2023-05-22Market Events
Meet Medicilon at SAPA-NE 25th Annual Conference

Date: Saturday, June 3rd, 2023

Location: Boston Marriott Cambridge

Learn more
2023-05-17Market Events
Stand Up for Science with Medicilon at 2023 BIO International Convention

Date: June 5-8, 2023

Location: Boston, MA

Booth: 2275-J

Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CAREERS
Talent Development
Employee Activities
Campus Recruitment
Social Recruitment
Campus Recruitment
Campus Recruitment
Social Recruitment
Social Recruitment
Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
CN
Contact Us
Close Button
Message
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global Clinical Research Organizations in 2021| Top 10 Global CDMO Enterprises| Preclinical Drug Development Process
May 19,2023
Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates
Antibody-Oligonucleotide Conjugates (AOCs) represent an emerging class of functionalized antibodies that have already been used in a wide variety of applications. Following let us introduce the evolution of nucleic acid delivery technologies,Conjugation mechanism of AOC.
More
Antibody-oligonucleotide conjugates (AOCs) —A new wave of drug conjugates
May 08,2023
Medicilon Flow Sorting Platform
Based on the technical basis of flow cytometry, the Medicilon flow sorting platform is widely used in scientific research and work in immunology, cell biology, oncology, hematology, drug development, and environmental testing. Medicilon flow cytometry team has extensive experience in experimental operation, flow sorting method development and data analysis.
More
Medicilon Flow Sorting Platform
May 08,2023
【Expert Report】Dr. Xingquan Ma: Medicinal Chemistry in Small Nucleic Acid Drug Discovery
On March 24, 2023, Dr. Xingquan Ma, SVP of the Chemistry Department of Medicilon, gave a report titled "Medicinal Chemistry in Small Nucleic Acid Drugs Discovery" during the IDC2023 4th Chemical New Drug and Improved New Drug R&D Forum. Medicilon can provide monomer synthesis and modification; oligonucleotide synthesis; delivery system synthesis and synthesis of oligonucleotide conjugates.
More
【Expert Report】Dr. Xingquan Ma: Medicinal Chemistry in Small Nucleic Acid Drug Discovery
May 04,2023
A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation
In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields.
More
A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp<sup>3</sup>-Sp<sup>2</sup> Bond Formation
Mar 03,2023
Whole-Process of Antibody Drug Development - Facilitate IND Declaration of Biological Drugs
The Medicilon antibody development platform has been deeply involved in the field of antibody drug research and development and their technical services include the ADA antibody development technical services and druggable antibody development technical services, ADA-free polyclonal antibody development, ADA mouse hybridoma monoclonal antibody development, phage display rabbit monoclonal antibody development services, mouse monoclonal antibody development technical services, mouse/rabbit single B cell antibody development technical services and other projects.
More
Whole-Process of Antibody Drug Development - Facilitate IND Declaration of Biological Drugs
Feb 24,2023
Beautiful Chemistry-Photoinduced Alkene Cleavage Using Nitroarenes
The oxidative cleavage of olefins is an important transformation in organic synthesis to obtain carbonyl functional groups such as ketones and aldehydes. Medicilon has integrated emerging methods of green chemistry into its services, using currently popular photoredox chemistry, electrochemisty, catalyst screening, continuous reactions, etc., to provide our customers with high-quality economic solutions.
More
Beautiful Chemistry-Photoinduced Alkene Cleavage Using Nitroarenes
Feb 17,2023
Come, Chat with ChatGPT regarding CRO
Almost overnight, the whole city chatted about ChatGPT. While people are admiring the omnipotence of AI, people also worry that their jobs will be taken away by AI one day...
More
Come, Chat with ChatGPT regarding CRO
Feb 17,2023
Market Prospects, Development Challenges and Countermeasures of Oligonucleotide Drugs
In recent years, with the advancement of related research and technology, nucleic acid drugs have ushered into rapid development, and the number of nucleic acid drugs approved for the global market is increasing yearly.
More
Market Prospects, Development Challenges and Countermeasures of Oligonucleotide Drugs
Feb 04,2023
World Cancer Day: Features of Popular Tumor Models in Oncology Drug Development
February 4th is the 24th World Cancer Day. Medicilon has been part of the great human effort to combat cancer since its founding in 2004. In order to better understand tumorigenesis, to foster cancer prevention and to develop novel anti- cancer therapy, Medicilon has been providing IND enabling preclinicalservice for 19 years, and has established close to 300 tumor evaluation model for R&D.
More
World Cancer Day: Features of Popular Tumor Models in Oncology Drug Development
Jan 05,2023
The Role of the Ames Test in Predicting the Genotoxicity of Impurity Compounds in Drugs
The Ames test is short-term in vitro test method for preliminary screening of the mutagenicity of chemical substances by using the properties of the reverse mutation of the histidine auxotrophic mutant strain of Salmonella typhimurium.
More
The Role of the Ames Test in Predicting the Genotoxicity of Impurity Compounds in Drugs
Stock Code
688202

Global

Address: 1 Broadway, Cambridge, MA02142 (America)

Tel: +1(626)986-9880(U.S. - West Coast)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 24, Seochojungang-ro 8-gril, Seocho-gu, Seoul, 06643 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->